<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T11:45:32Z</responseDate>
  <request identifier="oai:figshare.com:article/33967931" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33967931</identifier>
        <datestamp>2026-09-22T17:39:04Z</datestamp>
        <setSpec>category_15</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Anonymized dataset underlying the study findings.&lt;/p&gt;</dc:title>
          <dc:creator>Koray Samet Altınçekiç (25091315)</dc:creator>
          <dc:creator>Şevval Çelen (25091318)</dc:creator>
          <dc:creator>Osman Coşkun (25091321)</dc:creator>
          <dc:creator>Sinan Avcı (25091324)</dc:creator>
          <dc:creator>Selin Biçer Baikoğlu (25091327)</dc:creator>
          <dc:creator>Meltem Özağır (25091330)</dc:creator>
          <dc:creator>Suzan Dal (25091333)</dc:creator>
          <dc:creator>Orkun Akkoç (25091336)</dc:creator>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>five valid trials</dc:subject>
          <dc:subject>extended bootstrap estimates</dc:subject>
          <dc:subject>evaluated using 5</dc:subject>
          <dc:subject>assessed using ancova</dc:subject>
          <dc:subject>accelerated bootstrap replicates</dc:subject>
          <dc:subject>test reaction time</dc:subject>
          <dc:subject>extended nonlinear baseline</dc:subject>
          <dc:subject>control comparison depended</dc:subject>
          <dc:subject>baseline reaction time</dc:subject>
          <dc:subject>lower adjusted post</dc:subject>
          <dc:subject>different foam rolling</dc:subject>
          <dc:subject>dependent acute effects</dc:subject>
          <dc:subject>group randomized trial</dc:subject>
          <dc:subject>based (&amp;# 8722</dc:subject>
          <dc:subject>xlink "&gt; fr</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>foam rolling</dc:subject>
          <dc:subject>adjusted post</dc:subject>
          <dc:subject>acute effects</dc:subject>
          <dc:subject>control group</dc:subject>
          <dc:subject>test differences</dc:subject>
          <dc:subject>group interaction</dc:subject>
          <dc:subject>control difference</dc:subject>
          <dc:subject>&amp;# 8722</dc:subject>
          <dc:subject>u18 players</dc:subject>
          <dc:subject>trial score</dc:subject>
          <dc:subject>study examined</dc:subject>
          <dc:subject>sensitivity measures</dc:subject>
          <dc:subject>second protocol</dc:subject>
          <dc:subject>passive rest</dc:subject>
          <dc:subject>lowest value</dc:subject>
          <dc:subject>linearity assumptions</dc:subject>
          <dc:subject>interaction model</dc:subject>
          <dc:subject>independent benefit</dc:subject>
          <dc:subject>based analyses</dc:subject>
          <dc:subject>also higher</dc:subject>
          <dc:subject>allocated equally</dc:subject>
          <dc:subject>94 ms</dc:subject>
          <dc:subject>86 ms</dc:subject>
          <dc:subject>79 ms</dc:subject>
          <dc:subject>52 ms</dc:subject>
          <dc:subject>44 ms</dc:subject>
          <dc:subject>36 ms</dc:subject>
          <dc:subject>000 bias</dc:subject>
          <dc:description>&lt;div&gt;
&lt;p&gt;Objective&lt;/p&gt;&lt;p&gt;This study examined the acute effects of different foam rolling (FR) durations on dominant-hand visual reaction time in male youth basketball players.&lt;/p&gt;
&lt;p&gt;Methods&lt;/p&gt;&lt;p&gt;In this parallel-group randomized trial, 102 U16–U18 players were allocated equally to FR-A (30 seconds per region), FR-B (60 seconds per region), or passive rest. Five valid trials were recorded before and after the intervention. The lowest value was the primary best-trial score; the mean and median were sensitivity measures. Baseline-adjusted post-test differences were assessed using ANCOVA. Because the standard best-trial ANCOVA violated slope-homogeneity and linearity assumptions, an extended nonlinear baseline-interaction model was evaluated using 5,000 bias-corrected and accelerated bootstrap replicates. Mixed-design ANOVAs examined pre-to-post trajectories.&lt;/p&gt;
&lt;p&gt;Results&lt;/p&gt;&lt;p&gt;FR-A had lower adjusted post-test reaction time than FR-B under best-trial (difference = −21.86 ms, 95% CI: −30.31 to −13.41; adjusted p &lt; .01), mean-based (−12.36 ms, adjusted p &lt; .01), and median-based scoring (−10.94 ms, adjusted p = .03). The FR-A–control difference was significant in the standard best-trial ANCOVA (−15.44 ms, 95% CI: −24.12 to −6.76; adjusted p &lt; .01) and extended bootstrap comparison (−14.79 ms, adjusted p &lt; .01), but not in mean-based (adjusted p = .33) or median-based analyses (adjusted p = .39). Extended bootstrap estimates were also higher in FR-B than in the control group (9.52 ms, adjusted p = .01). Because this model contained baseline interactions, these contrasts represented average rather than constant differences across baseline values. The time × group interaction was significant only for best-trial scoring (p &lt; .01).&lt;/p&gt;
&lt;p&gt;Conclusion&lt;/p&gt;&lt;p&gt;FR-A had consistently lower adjusted reaction time than FR-B across all scoring methods. However, the FR-A–control comparison depended on baseline reaction time and scoring method. Thus, the findings do not establish a scoring-independent benefit of the 30-second protocol over passive rest or support a firm practical recommendation.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-09-22T17:39:01Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358357.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Anonymized_dataset_underlying_the_study_findings_p_/33967931</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
